Nishadil
Signup Signin
Delhi | 25°C (windy)
The Mind Behind Miracles: Daniel Skovronsky's Blueprint for Eli Lilly's R&D Revolution

The Mind Behind Miracles: Daniel Skovronsky's Blueprint for Eli Lilly's R&D Revolution
The GLP-1 Gold Rush: Why Morgan Stanley Just Downgraded Novo Nordisk Amid Fierce Competition

The GLP-1 Gold Rush: Why Morgan Stanley Just Downgraded Novo Nordisk Amid Fierce Competition
The Weight Loss Revolution: Drugs vs. Surgery – Which Path is Right for You?

The Weight Loss Revolution: Drugs vs. Surgery – Which Path is Right for You?
Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s

Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s
Beyond Blood Sugar: Ozempic and Zepbound's Unexpected Promise in Psoriasis Treatment

Beyond Blood Sugar: Ozempic and Zepbound's Unexpected Promise in Psoriasis Treatment
The GLP-1 Revolution: Why the Market's Reaction to Novo Nordisk and Eli Lilly is Lagging

The GLP-1 Revolution: Why the Market's Reaction to Novo Nordisk and Eli Lilly is Lagging
FDA Steps In: Big Pharma's Weight-Loss Claims Under Scrutiny After Oprah Video

FDA Steps In: Big Pharma's Weight-Loss Claims Under Scrutiny After Oprah Video
The Next Frontier: Eli Lilly and Novo Nordisk Gear Up for a Revolution in Oral Obesity Treatment

The Next Frontier: Eli Lilly and Novo Nordisk Gear Up for a Revolution in Oral Obesity Treatment
The Ozempic Effect: How Weight-Loss Drugs Are Reshaping Economies and Creating Thousands of Jobs

The Ozempic Effect: How Weight-Loss Drugs Are Reshaping Economies and Creating Thousands of Jobs
The Weight of Success: Why Breakthrough Obesity Drugs Are a Budget Breaker

The Weight of Success: Why Breakthrough Obesity Drugs Are a Budget Breaker
The Cost-Benefit Revolution: GLP-1 Drugs Deemed Value-Packed, But Price Tags Loom Large

The Cost-Benefit Revolution: GLP-1 Drugs Deemed Value-Packed, But Price Tags Loom Large
Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status
Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection

Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection
GLP-1 Medications: The Dawn of a New Therapeutic Era or Just Hype?

GLP-1 Medications: The Dawn of a New Therapeutic Era or Just Hype?
The GLP-1 Revolution: Unpacking the Future of Weight Loss

The GLP-1 Revolution: Unpacking the Future of Weight Loss
Serena Williams Unveils Candid Thoughts on Motherhood, Body Image, and GLP-1 Weight Loss Drugs

Serena Williams Unveils Candid Thoughts on Motherhood, Body Image, and GLP-1 Weight Loss Drugs
Beyond the Scale: Preserving Muscle While Losing Weight with GLP-1 Medications

Beyond the Scale: Preserving Muscle While Losing Weight with GLP-1 Medications
The GLP-1 Revolution: Striking the Balance Between Weight Loss and Muscle Preservation

The GLP-1 Revolution: Striking the Balance Between Weight Loss and Muscle Preservation
Beyond the Scale: Protecting Your Muscle While on GLP-1 Weight Loss Medications

Beyond the Scale: Protecting Your Muscle While on GLP-1 Weight Loss Medications
The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?
The Wild West of Weight Loss: Unpacking the Perils of Online Compounded GLP-1s

The Wild West of Weight Loss: Unpacking the Perils of Online Compounded GLP-1s
FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs

FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs
Load more..